News | March 06, 2024
Bayer aims to enhance performance and regain strategic flexibility by 2026
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The initiative will focus on advocating for cleaner air
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
All claims against the company in the litigation have now been dismissed.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Subscribe To Our Newsletter & Stay Updated
